Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Funding for Selected Pathogens, Diseases, and Conditions, FY 2011

NIAID reports how appropriated funds are spent in different categories and classifications, including by pathogen (disease-causing organism), specific disease or condition, and research area. The table below provides funding levels for areas of interest to NIAID stakeholders. These areas do not represent the entire NIAID research portfolio. Funding for these areas can overlap and does not add up to the total NIAID budget. For example, funding for West Nile virus is represented in several areas, including vector-borne diseases, tropical medicine, and infectious diseases.

How NIAID Reports Expenditures

  • NIH Research, Condition, and Disease Categories (RCDC)—In response to the NIH Reform Act of 2006 (Public Law No. 109-482), the National Institutes of Health (NIH) developed a consistent and transparent system to describe how NIH categorizes its research. RCDC reflects NIH funding levels in 229 research, condition, and disease categories.
  • Funding for NIAID research areas not reported through the RCDC process is coded and reported using the process in place before RCDC was implemented in FY 2008.


NIAID Funding for Selected Pathogens, Diseases, and Conditions – FY 2011

Pathogen, Disease, or Condition Dollars (in Thousands) Pathogen, Disease, or Condition Dollars (in Thousands)
Allergy  $      51,243 Leishmaniasis  $      18,662
Allergic Rhinitis1 5,741 Lupus1 47,112
Food Allergy1 28,385 Lyme Disease1 18,238
Anaphylaxis 5,145 Malaria1 114,461
Anthrax1 72,935 Multiple Sclerosis1 30,991
Arthritis1 34,553 Parasitic Diseases 258,236
Asthma1 56,594 Pandemic Influenza 243,112
Autoimmune Disease1 190,085 Pediatric (Research)1 260,324
Cholera 19,595 Pediatric AIDS 67,106
Dengue Virus 42,511 Pneumonia and Influenza1 300,166
Diabetes1 33,687 Primary Immune Deficiency Diseases 30,392
Diarrheal Diseases 177,588 Respiratory Diseases, Infectious 345,558
Digestive Diseases1 316,515 Sexually Transmitted Diseases / Herpes1 120,104
Ebola 42,879 Smallpox1 63,232
Emerging Infectious Diseases1 1,740,645 Staphylococcus aureus 87,849
Fungal Diseases 57,381 Methicillin-Resistant S. aureus 58,715
Hepatitis1 79,927 Transmissible Spongiform Encephalopathies / Prions 12,264
Hepatitis C1 51,283 Tropical Medicine2 507,114
HIV/AIDS 1,563,349 Tuberculosis1 157,950
Infectious Diseases, including HIV/AIDS1 2,575,418 Vector-Borne Diseases1 393,499
Inflammatory Bowel Disease1 22,532 West Nile Virus1 62,032
Other Research Dollars (in Thousands) Other Research Dollars (in Thousands)
Antimicrobial Resistance1 275,170 Immune Tolerance 167,129
Biodefense 1,665,098 Prevention1 1,457,605
Antibiotics/Antivirals 339,840 Rare Diseases1 762,464
Basic Research 897,925 Stem Cell Research1 40,124
Chemical Countermeasures Research 47,890 Topical Microbicides1 76,190
Diagnostic 252,368 Translational Research 1,782,775
Radiological/Nuclear Research3 47,408 Transplantation1 124,600
Vaccines 337,414 Vaccine Development 1,277,812
Comparative Effectiveness Research1 67,614 HPV and/or Cervical Cancer Vaccines1 7,017
Food Safety1 219,022 Vaccine-Related (AIDS) 467,799

1Represents topics and funding levels reported using the NIH RCDC process
2Includes neglected tropical diseases
3NIAID coordinates/manages these programs on behalf of NIH.​

Last Updated June 11, 2012